ATE133422T1 - Peptide und deren benutzung - Google Patents

Peptide und deren benutzung

Info

Publication number
ATE133422T1
ATE133422T1 AT90119624T AT90119624T ATE133422T1 AT E133422 T1 ATE133422 T1 AT E133422T1 AT 90119624 T AT90119624 T AT 90119624T AT 90119624 T AT90119624 T AT 90119624T AT E133422 T1 ATE133422 T1 AT E133422T1
Authority
AT
Austria
Prior art keywords
peptide
adult
antibody
associated antigen
cell leukemia
Prior art date
Application number
AT90119624T
Other languages
English (en)
Inventor
Yoshiaki Maeda
Hiroshi Shiraki
Yukiko Washitani
Naotaka Kuroda
Kyoko Yamada
Kiichiro Oka
Toshihiko Namba
Original Assignee
Kuraray Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kuraray Co filed Critical Kuraray Co
Application granted granted Critical
Publication of ATE133422T1 publication Critical patent/ATE133422T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57426—Specifically defined cancers leukemia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90119624T 1989-10-13 1990-10-12 Peptide und deren benutzung ATE133422T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1266983A JP2807287B2 (ja) 1989-10-13 1989-10-13 ペプチドおよびその用途

Publications (1)

Publication Number Publication Date
ATE133422T1 true ATE133422T1 (de) 1996-02-15

Family

ID=17438426

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90119624T ATE133422T1 (de) 1989-10-13 1990-10-12 Peptide und deren benutzung

Country Status (5)

Country Link
US (1) US5194586A (de)
EP (1) EP0423649B1 (de)
JP (1) JP2807287B2 (de)
AT (1) ATE133422T1 (de)
DE (1) DE69025023T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681696A (en) * 1987-01-09 1997-10-28 United Biomedical, Inc. Synthetic peptide compositions with immunoreactivities to antibodies to HTLV
JPH07502483A (ja) * 1990-08-29 1995-03-16 アメリカ合衆国 新規ペプチド抗原およびそれを用いるイムノアッセイ、試験キットおよびワクチン
US5652211A (en) * 1991-02-11 1997-07-29 Biosynth S.R.L. Peptides for neutralizing the toxicity of Lipid A
SE9202318L (sv) * 1992-08-10 1994-02-11 Replico Medical Ab Nya peptider, diagnostiska antigen, användning därav, vacciner och medikamenter
CZ295838B6 (cs) * 1996-09-09 2005-11-16 Zealand Pharma A/S Způsob výroby peptidů
WO1999046283A1 (en) * 1998-03-09 1999-09-16 Zealand Pharmaceuticals A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US20040223966A1 (en) * 2002-10-25 2004-11-11 Wolfman Neil M. ActRIIB fusion polypeptides and uses therefor
GB0703175D0 (en) * 2007-02-20 2007-03-28 Ge Healthcare Bio Sciences Ab Polymeric device suitable for ultraviolet detection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2182667B1 (de) * 1972-05-03 1978-03-03 Rhone Poulenc Ind
EP0107053B1 (de) * 1982-09-30 1989-09-13 Japanese Foundation For Cancer Research Menschliche dem Leukämie-Virus verwandte Peptiden, deren Antikörper und Verfahren zu deren Herstellung
AU600224B2 (en) * 1984-09-19 1990-08-09 Regents Of The University Of California, The Retroviral polypeptides associated with human cellular transformation
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
WO1988005783A1 (en) * 1987-01-28 1988-08-11 Ortho Pharmaceutical Corporation Immunosuppressive peptides and methods of use
SE467542B (sv) * 1989-06-13 1992-08-03 Syntello Ab Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Also Published As

Publication number Publication date
JPH03127799A (ja) 1991-05-30
DE69025023T2 (de) 1996-08-22
DE69025023D1 (de) 1996-03-07
US5194586A (en) 1993-03-16
EP0423649A1 (de) 1991-04-24
EP0423649B1 (de) 1996-01-24
JP2807287B2 (ja) 1998-10-08

Similar Documents

Publication Publication Date Title
ES2075196T3 (es) Metodo para el uso y la sintesis de peptidos.
ATE320448T1 (de) Gereinigte primate clta-8 antigene und verwandte reagenzien
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
NZ237535A (en) Carrier for binding anti-phospholipid antibodies, its use in immunoassays and kits and blood protein which enhances binding ability of antiphospholipid antibody
DE69025023D1 (de) Peptide und deren Benutzung
FI925321A0 (fi) Immunodiagnostiskt ledinflammationstest
ATE133993T1 (de) Protein-antikrebsmittel
DK0580672T3 (da) Syntetisk CDw52-(CAMPATH-1)-peptidantigen
EP0404935A4 (en) Synthetic peptide compositions with immunoreactivities to antibodies to htlv-1
AU3825389A (en) Hcg peptides for use in antibody purification procedures
JPS6488367A (en) Immobilized antibody
ES2109225T3 (es) Anticuerpos, su produccion y uso.
DE69233666D1 (de) Verzweigte Peptide zum Nachweis von Antikörpern
EP0443880A3 (en) Assay for equine infectious anemia virus
RU97109300A (ru) Иммуносорбент для обнаружения антител к ядерному белку вируса гепатита с в сыворотке крови

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties